University of Utah research spins off new firm. LineaGen to develop biomarker tests to target genetic disease
| December 20, 2007 |  View for printing |
A Utah company that plans to develop biomarker tests to diagnose genetic disease was formally launched Wednesday, with the announcement that it has closed a $5.8 million funding round.
LineaGen http://www.lineagen.com is a company spun off research at the University of Utah, which has discovered more genes related to diseases than any other university. Besides developing diagnostic tools using biomarkers, the company plans to license intellectual property to companies to help develop treatments.
By Lois M. Collins Deseret Morning News
Full Story: http://www.deseretnews.com/article/1 ... 470,00.html
No reader comments so far. Be the first to comment by clicking the button below.
Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.
